Pablo J Cagnoni
CIK 1205703 · View on SEC EDGAR ↗
First SEC filing: June 3, 2026 · Latest: June 3, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 19, 2026 | INCY | S 10b5-1 | 10,801 | $125.56 | $1,356,174 | 183,200 Direct | -5.57% | Disposed | 1.6% (price as of 2026-08-21) |
| Aug. 12, 2026 | INCY | S | 10,803 | $120.04 | $1,296,792 | 194,001 Direct | -5.27% | Disposed | 6.3% (price as of 2026-08-21) |
| Aug. 5, 2026 | INCY | S | 10,640 | $122.69 | $1,305,422 | 204,804 Direct | -4.94% | Disposed | 4.0% (price as of 2026-08-21) |
| July 31, 2026 | INCY | S | 15,888 | $119.70 | $1,901,794 | 215,444 Direct | -6.87% | Disposed | 6.6% (price as of 2026-08-21) |
| April 17, 2026 | INCY | S | 18,667 | $96.50 | $1,801,366 | 262,692 Direct | -6.63% | Disposed | 32.2% (price as of 2026-08-21) |
| March 17, 2026 | INCY | S | 18,667 | $94.24 | $1,759,178 | 234,800 Direct | -7.36% | Disposed | 35.4% (price as of 2026-08-21) |
| Feb. 19, 2026 | INCY | S | 18,668 | $100.91 | $1,883,788 | 234,800 Direct | -7.37% | Disposed | 26.4% (price as of 2026-08-21) |
| Nov. 19, 2019 | CRSP | S 10b5-1 | 7,500 | $62.00 | $465,000 | 0 Direct | -100.00% | Disposed | -4.0% (price as of 2026-08-21) |
| Nov. 12, 2019 | CRSP | S 10b5-1 | 7,500 | $55.00 | $412,500 | 0 Direct | -100.00% | Disposed | 8.3% (price as of 2026-08-21) |
| Oct. 30, 2019 | CRSP | S 10b5-1 | 7,500 | $52.00 | $390,000 | 0 Direct | -100.00% | Disposed | 14.5% (price as of 2026-08-21) |
| July 5, 2018 | CRSP | S 10b5-1 | 1,684 | $62.00 | $104,408 | 0 Direct | -100.00% | Disposed | -4.0% (price as of 2026-08-21) |
| July 3, 2018 | CRSP | S 10b5-1 | 5,816 | $62.00 | $360,592 | 0 Direct | -100.00% | Disposed | -4.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 16, 2026 | INCY | Employee Stock Option (right to buy) | Common Stock (57,861) | $116.65 | July 15, 2036 | 57,861 | Acquired |
| July 16, 2026 | INCY | Performance Shares | Common Stock (33,508) | — | July 16, 2029 | 33,508 | Acquired |
| April 17, 2026 | INCY | Employee Stock Option (right to buy) | Common Stock (12,590) | $71.93 | Jan. 16, 2035 | 12,590 | Disposed |
| April 17, 2026 | INCY | Employee Stock Option (right to buy) | Common Stock (6,077) | $64.25 | July 14, 2034 | 6,077 | Disposed |
| March 17, 2026 | INCY | Employee Stock Option (right to buy) | Common Stock (11,501) | $64.25 | July 14, 2034 | 11,501 | Disposed |
| March 17, 2026 | INCY | Employee Stock Option (right to buy) | Common Stock (7,166) | $61.18 | Jan. 17, 2034 | 7,166 | Disposed |
| Feb. 19, 2026 | INCY | Employee Stock Option (right to buy) | Common Stock (5,575) | $61.18 | Jan. 17, 2034 | 5,575 | Disposed |
| Feb. 19, 2026 | INCY | Employee Stock Option (right to buy) | Common Stock (13,093) | $61.76 | July 13, 2033 | 13,093 | Disposed |
| Jan. 16, 2026 | INCY | Employee Stock Option (right to buy) | Common Stock (28,475) | $106.21 | Jan. 15, 2036 | 28,475 | Acquired |
| July 15, 2025 | INCY | Employee Stock Option (right to buy) | Common Stock (39,471) | $68.25 | July 14, 2035 | 39,471 | Acquired |
| July 15, 2025 | INCY | Performance Shares | Common Stock (43,846) | — | July 15, 2028 | 43,846 | Acquired |
| Jan. 17, 2025 | INCY | Employee Stock Option (right to buy) | Common Stock (40,289) | $71.93 | Jan. 16, 2035 | 40,289 | Acquired |
| July 15, 2024 | INCY | Employee Stock Option (right to buy) | Common Stock (44,411) | $64.25 | July 14, 2034 | 44,411 | Acquired |
| Jan. 18, 2024 | INCY | Employee Stock Option (right to buy) | Common Stock (21,843) | $61.18 | Jan. 17, 2034 | 21,843 | Acquired |
| July 14, 2023 | INCY | Employee Stock Option (right to buy) | Common Stock (20,275) | $61.76 | July 13, 2033 | 20,275 | Acquired |
| Nov. 19, 2019 | CRSP | Stock Option (Right to Buy) | Common Shares (7,500) | $5.59 | Nov. 4, 2025 | 7,500 | Disposed |
| Nov. 12, 2019 | CRSP | Stock Option (Right to Buy) | Common Shares (7,500) | $5.59 | Nov. 4, 2025 | 7,500 | Disposed |
| Oct. 30, 2019 | CRSP | Stock Option (Right to Buy) | Common Shares (7,500) | $5.59 | Nov. 4, 2025 | 7,500 | Disposed |
| June 11, 2019 | CRSP | Stock Option (Right to Buy) | Common Shares (15,000) | $43.52 | June 11, 2029 | 15,000 | Acquired |
| July 5, 2018 | CRSP | Stock Option (Right to Buy) | Common Shares (1,684) | $5.59 | Nov. 4, 2025 | 1,684 | Acquired |
| July 3, 2018 | CRSP | Stock Option (Right to Buy) | Common Shares (5,816) | $5.59 | Nov. 4, 2025 | 5,816 | Acquired |
| June 15, 2018 | CRSP | Stock Option (Right to Buy) | Common Shares (15,000) | $59.31 | June 15, 2018 | 15,000 | Acquired |
| May 31, 2017 | CRSP | Stock Option (Right to Buy) | Common Shares (15,000) | $13.62 | May 31, 2027 | 15,000 | Acquired |
| Oct. 18, 2016 | CRSP | Stock Option (Right to Buy) | Common Shares (15,000) | $14.00 | Oct. 18, 2026 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
INCY
President and Global Head of Research and Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $966,516 | — | — | — | $1,007,027 | — | $97,881 | $8,838,961 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.